Related Experiment Video
Updated: Jun 4, 2026

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors
Published on: September 20, 2016
Mutation Detection inTGF-β Receptors
1Ireland Cancer Center, University Hospitals of Cleveland, Cleveland, OH.
Abstract:
The transforming growth factor β (TGF-β) receptors are an important class of tumor suppressor gene. TGF-β markedly inhibits the growth of many epithelial cell types; whereas in contrast, cancers of many different tissue types are commonly TGF-β resistant (10). Many cancer cell lines are resistant to the growth suppressive effects of TGF-β and display evidence of disruption of TGF-β signal transduction (10,4,10). To date, this resistance appears to often result from mutations in the TGF-β receptors or the smad family of TGF-β signaling proteins (5,11,12,14,16).
Insights
Transforming growth factor β (TGF-β) receptors are key tumor suppressors. Cancer cells often develop resistance to TGF-β
Area of Science:
- Oncology
- Molecular Biology
- Cell Signaling
Background:
- Transforming growth factor β (TGF-β) receptors function as critical tumor suppressors.
- TGF-β normally inhibits epithelial cell growth, but many cancers exhibit resistance.
- This resistance is linked to disruptions in TGF-β signal transduction pathways.
Purpose of the Study:
- To investigate the molecular mechanisms underlying TGF-β resistance in cancer.
- To identify key genetic alterations contributing to impaired TGF-β signaling.
Main Methods:
- Analysis of cancer cell lines exhibiting resistance to TGF-β.
- Examination of mutations within TGF-β receptors and associated signaling proteins.
Main Results:
- Many cancer cell lines demonstrate resistance to the growth-inhibitory effects of TGF-β.
- Disrupted TGF-β signal transduction is evident in resistant cancer cells.
- Mutations in TGF-β receptors and smad proteins are frequently observed.
Conclusions:
- Mutations in TGF-β receptors or smad proteins are a common cause of TGF-β resistance in cancer.
- Understanding these mutations is crucial for developing targeted cancer therapies.
Related Concept Videos
TGF - β Signaling Pathway
Mitogens and the Cell Cycle
